High prevalence of neutralizing activity against multiple unrelated human immunodeficiency virus type 1 (HIV-1) subtype B variants in sera from HIV-1 subtype B-infected individuals: evidence for subtype-specific rather than strain-specific neutralizing activity

Eitemau Tebyg

• Longitudinal Analysis of Early HIV-1-Specific Neutralizing Activity in an Elite Neutralizer and in Five Patients Who Developed Cross-Reactive Neutralizing Activity
  gan: Euler, Zelda, et al.
  Cyhoeddwyd: (2012)
• Rapid Escape from Preserved Cross-Reactive Neutralizing Humoral Immunity without Loss of Viral Fitness in HIV-1-Infected Progressors and Long-Term Nonprogressors
  gan: van Gils, Marit J., et al.
  Cyhoeddwyd: (2010)
• P04-50 LB. Prevalence of cross-reactive HIV-1 neutralizing activity in HIV-1 infected patients with rapid or slow disease progression
  gan: van Gils, MJ, et al.
  Cyhoeddwyd: (2009)
• HIV-1 envelope characteristics that coincide with the development of cross-reactive neutralizing activity in HIV-1 infected patients
  gan: van den Kerkhof, Tom, et al.
  Cyhoeddwyd: (2011)
• Evolution of Human Immunodeficiency Virus Type 1 in a Patient with Cross-Reactive Neutralizing Activity in Serum
  gan: van Gils, Marit J., et al.
  Cyhoeddwyd: (2011)